This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Investigations

Authoring team

The investigation of dermatitis herpetiformis should include the following:

  • blood tests for celiac disease
    • immunology study
    • IgA antiendomysial antibodies
    • IgA anti-tissue transglutaminase antibodies (sensitivity 98.5%, specificity 98%)
    • useful additional test if serology supports the diagnosis of coeliac disease include
      • FBC
      • blood film
      • haematinics (vitamin B12, folate, ferritin)
      • urea and electrolytes may
      • thyroid function test – due to the association of thyroid disease with both coeliac disease and dermatitis herpetiformis
    • skin biopsies
      • lesional skin of patients with DH will reveal epidermal vesicles and blisters associated with accumulation of neutrophils at the papillary tips on histopathological study
      • a second biopsy consisting of peri-lesional skin (within 2cm of the blister) is used for direct immunofluorescence
        • is the gold standard for the diagnosis of DH
        • will show granular IgA deposits along the dermal-epidermal junction and on top of the dermal papillae

If blood tests point towards a diagnosis of celiac disease, a referral to secondary care is recommended.

Note:

  • once the diagnosis is confirmed, DH should be considered as a cutaneous manifestation of and pathognomonic for, coeliac disease. Hence, duodenal or jejunal biopsies are not considered necessary for further diagnosis

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.